A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease

NCT03462121 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild to Moderate Dementia Due to Alzheimer's Disease
With or Without Coexisting Cerebrovascular Disease

Interventions

DRUG: RPh201
OTHER: Placebo

Sponsor

Regenera Pharma Ltd